Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 21, 2022, titled “Glenmark is the first company to launch in India a Triple FDC of Teneligliptin +Pioglitazone……
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
